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A Simple and Sensitive
Spectrophotometric Determination of Monoamine Oxidase Activity1)
By W. CHRIST, DAGMAR RAKOW, M. FERNANDES and S. MAGOUR
Institut für Neuropsychopbarmakologie der Freien Universität Berlin
(Eingegangen am 9. Mai 1973)
A simple, sensitive Spectrophotometric determination of monoamine oxidase activity from tissue homogenates is described. This method
is based on the high extinction coefficient of 4-hydroxy-3-methoxy-benzaldehyde (vanillin) at 345 nm at pH ~ 11.7. Vanillin is formed by
inonoamine oxidase when 4-hydroxy-3-methoxy-benzylamine is used as substrate. The primary oxidation product, 4-hydroxy-3-methoxy-
benzaldehyde, is not further metabolized by aldehyde reductase or aldehyde dehydrogenase.
The apparent Km value of 4-hydroxy-3-methoxy-benzylamine for monoamine oxidase of rat brain is 150 to 180 /^mol/1 (pH 7.0). The pH
optimum of the rat brain monoamine oxidase with this substrate was found to be at about 9.0. Inhibition of monoamine oxidase of rat
brain after pretreatment of rats with iproniazid, pargyline and tranylcypromine was investigated with this method. The data were analyzed
according to LINEWEAVER and BUR .
Eine einfache, empfindliche und schnelle spektrophotometrische Bestimmungsmethode der Monoamin-Oxidase-Aktivität in Gewebe-
homogenaten wird beschrieben. Die Methode beruht auf dem hohen Extinktionskoeffizienten von 4-Hydroxy-3-methoxy-benzaldehyd
(Vanillin) bei 345 nm und bei einem pH von 11,7. Dieser Aldehyd entsteht, wenn man der Monoamin-Oxidase 4-Hydroxy-3-methoxy-
benzylamin als Substrat anbietet. Vanillin wird weder durch die Aldehyd-Reduktase noch durch die Aldehyd-Dehydrogenase weiter
metabolisiert.
Der scheinbare Km-Wert des 4-Hydroxy-3-rhethoxy-benzylamins liegt für die Monoamin-Oxidase aus Rattengehirn bei 150—180 //mol/1
(pH 7,0) und das pH Optimum liegt für dieses Substrat bei etwa 9,0.
Es wurde die Hemmung der Monoamin-Oxidase-Aktivität des Rattengehirns nach in vitro-Vorbehandlung der Ratten mit Monoamin-
Oxidase-Inhibitoren wie Iproniazid, Pargylin und Tranylcypromin mit dieser Methode untersucht. Die Ergebnisse wurden in LINE-
WEAVER-BuRK-Diagrammen ausgewertet.
Monoamine oxidase (MAO) [monoamine: O2 oxido-
reductase (deaminating) EC 1.4.3.4] catalyzes the
oxidative deamination of a great variety of monoamines.
The aldehydes originating from this reaction are then
either reduced by aldehyde reductase2) (EC 1.1.1.2) to
the corresponding alcohol or oxidized by aldehyde
dehydrogenase (EC 1.2.1.3) to carbonic acids. The
possibility cannot be excluded that these reaction-
products might interfere with some of the methods
used for the determination of monoamine oxidase
activity. Most methods for the estimation of mono-
amine oxidase are based on the measurement of oxygen
consumption or the determination of substrate dis-
appearance by Spectrophotometric and fluorometric
methods (1). More recently radiometric procedures
have been introduced using e. g. 14C-tyramine and
14C-tryptamine as substrates (1).
The method presented in this paper is based on the
high absorption of 4-hydroxy-3-methoxy-benzaldehyde
(vanillin) at 345 nm at pH - 11.7. This aldehyde is
formed when monoamine oxidase acts on 4-hydroxy-
3-methoxy-benzylamine as substrate.
*) A preliminary report of this study was presented at the 14th
Frühjahrstagung der Deutschen Pharmakologischen Gesellschaft
in Mainz, 1973 (12).




4-Hydroxy-3-methoxy-benzylamine · HC1; 4-hydroxy-3-methoxy-
benzaldehyde (vanillin) and 4-hydroxy-3-methoxy-benzoic acid
(vanillic acid) were purchased from EGA-Chemie, 7924 Stein-
heim, Germany.
Iproniazid (Marsilid) and Pargyline · HC1 were gifts of Hoffmann-
La Roche AG, Basel, Switzerland and of Abbott Laboratories,
North Chicago, Illinois, USA, respectively.
Tranylcypromine and Harmaline · HC1 were obtained from Sigma,
St. Louis, Missouri, USA; D-Amphetamine-sulphate and 4-
nitrobenzaldehyde were supplied by E. Merck AG, Darmstadt,
Germany. All substances mentioned were used \vithout further
purification \vith the exception of vanillic acid, which was re-
crystallized from hot water.
Thin Layer Chromatography
For the identification of vanillic acid in the presence of vanillin
pre-coated silica gel plates (Merck) were used with the following
solvent mixture: toluene/chloroform/acetone (40 ml-j-25 ml-f-
35 ml).
Animals
Female albino rats, Wistar breed, weighing 160—220 g were
obtained from Tierzuchtfarm Hoffmann, Berlin. The rats were
fed with standard diet (Altromin R 10) and tap water ad libitum.
Assay of NADPH-l inked a ldehyde reductase f rom
brain (ox and rat)
Aldehyde reductase was purified according to TABAKOFF and
ERWIN (2) up to the column Chromatographie step. The crude
enzyme thus obtained was used For the determination of the in-
hibitory constant of vanillin according to LINEWEAVER and BURK
and HUNTER and DOWNS (3). The reductase activity was assayed
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spcctrophotometrically. The reaction mixtures used consisted of:
crude enzyme protein (0.42 mg ** 0.0042 U*), NADPH (from
13 to 150μπιο1/1), 4-nitrobenzaldehyde (217^mol/l) and phos-
phate buffer (0.1 mol/1; pH 7.0) in a total volume of 3.0 ml. The
reaction was started by the addition of the aldehyde. The rate of
coenzyme oxidation was observed by following the decrease in
absorbance at λ = 340 nm at 25°C with a Beckman DK 2A
spectrpphotometer.
Assay procedure of monoamine oxidase
Rats were decapitated and the tissues (brain, heart and liver)
excised and homogenized (Pptter-Elvehjem) in chilled isotonic
KC1 (1 + 9; w/v). Homogenates of heart and liver were filtered
through 4 layers of cheese cloth before use.
These procedures were performed at +4°C. For standard assays
0.5ml of brain and heart homogenate, respectively, was used
whereas liver homogenate was added in a volume not exceeding
0.2ml. If 0.5ml or more of liver homogenate was used, the
recovery of vanillin was not constant.
Reaction mixtures were prepared in 25 ml Erlenmeyer flasks
immersed in ice.
The standard assay contained in a final volume of 5.0ml: tissue
homogenate; 0.05—1.0 ml of 4-hydroxy-3-methoxy-benzylamine
hydrochloride solution (substrate concentration from 0.05 to
lmmol/1); phosphate buffer (0.1 mol/1; pH 7.0). Samples are
incubated for 30 min at 37°C in a Dubnoff shaker under air. The
reaction was stopped by the addition of 0.46 ml of HC1O4 (60%).
After centrifugation (for 15 min at 40,000g) 5.0 ml of the super-
natant was taken pf and the vanillin formed was extracted into
10 ml of toluene (by shaking for 20 min). From a 8.0 ml aliquot
of the toluene layer the aldehyde was reextracted into 4.0ml
1 mol/1 K2CO3 (by shaking for 5 min). After centrifugation the
absorbance of vanillin was determined at 345 nm using a Zeiss
PMQ II spectrophotometer. Vanillin is stable in 1 mol/1 K2CO3
for at least 3 h. ,
A blank was run with each determination arid was prepared by
adding HC1O4 to the non-incubated assay mixture.
The reaction was linear with time for at least 45 min and with
homogenate concentrations from 10 to 150 mg (brain) and from
10 to 100 mg (liver) wet weight. Under our experimental con-
ditions the recovery of vanillin was 75—76%.
In contrast to the mitochondria-bound monoamine oxidase from
brain, heart and liver, the serum monoamine oxidase did not
accept 4-hydroxy-3-methoxy-benzylamine as substrate.
For the determination of monoamine oxidase activity in the
hypothalamus a slightly modified assay was used: 4—5 hypo-
thalami were pooled and homogenized in KC1 at the same ratio
as given above. Only 2.5 ml were used for incubation and further
assay (performed with half volumes).
Calculations
The extinction coefficient (αη2/μηιο1) used was 26.1 for vanillin at
345 nm in 1 mol/1 K2CO3. The activity of monoamine oxidase can
be calculated as follows (for rat brain homogenate):
zlE345 measured X 0.185 = nmoles vanillin formed/minute · g
wet weight.
Results
This method has the following advantages:
In incubation mixtures with 4-hydroxy-3-methoxy-
benzylamine as substrate for monoamine oxidase the
aldehyde (vanillin) is the only product formed. Under
our experimental conditions vanillin is not further
metabolized, which depends on the fact that vanillin
is an inhibitor of the NADPH-linked aldehyde re-
ductase from brain (Kr value: 57μιηο1/1) and that
vanillin is no substrate for the aldehyde dehydrogenase
in brain homogenate. Thus, the formation of 4-hy-
!) l U = 1 ^mol/min
droxy-3-methoxy-benzoic acid (vanillic acid) in assays
with brain homogenate could not be detected by thin-
layer chromatography.
As vanillin does not seem to undergo further enzymic
metabolism our method enables us to investigate
whether certain drugs, the so-called monoamine oxidase-
inhibitors, are really acting only on monoamine oxidase
or on other enzymes as well. Some of these "mono-
amine oxidase-irihibitors" are relatively non-specific
and also inhibit other enzyme-catalyzed reactions. The
phenylethylhydrazines have also been reported as
inhibitors of the NAD+-linked aldehyde dehydro-
genase from brain (4). The determination of mono-
amine oxidase-activity with 14C^tryptamine as Sub-
strate is based on the extraction and counting of 14C-
indoleacetic acid (5), which is a product of aldehyde-
dehydrogenase catalyzed reaction. Therefore, giVen
that aldehyde-dehydrogenase is more strongly in-
hibited by a so-called "monoamine oxidase-inhibitor"
than monoamine oxidase itself the results obtained may
give rise to misleading interpretations.
An additional advantage of our method is the high
extinction coefficient of vanillin at 345 nm in 1 mol/1
K2CO3. This enables us to use relatively low substrate
concentrations (less than 50/jmol/l), which are the
same as those used in radiometric procedures.
Our method takes advantage of a spectrophotometric
measurement at a higher wavelength (345 rim). Thus,
there are only few substances in the incubation mix-
ture, which could interfere with the absorbance due to
vanillin. Of the three possible metabolites in the incubation
mixture (4-hydroxy-3-methoxy-benzylamine, vanillin
and vanillic acid) only vanillin shows an absorption




Ultraviolet absorption spectra of 4-hydroxy-3-methoxy-benzaldehyde(vanillin) , 4-hydroxy^3-methoxy-benzoic acid (vanillic acid)
- — and 4-hydroxy-3-methoxy-benzyIarnine — ·. in 1 mol/I
KaCO,
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Km-value and maximal velocity
Under the conditions selected (0.1 mol/1 phosphate
buffer; pH 7.0), the apparent Km-value of 4-hydroxy-3-
methoxy-benfcyJamine is 150 to 180^mol/l for mono-
amine oxidasc of rat brain. The Km-values of 5-hydroxy-
tryptaminc, noradrenaline and tyramine for rat and
mouse brain monoaminc oxidasc in air were about
70,250 and 100 //mol/1 (at 25°C and pH 7.4) respectively
(6).
The maximum reaction rate for 4-hydroxy-3-methoxy-
bcnsylaminc for rat brain monoamine oxidasc is about
0.128^moles/minute and g wet weight (pH 7.0).
These data suggest that, as a substrate for the mono-
amine oxidase, 4-hydroxy-3-methoxy-ben2ylamine can
be compared with the physiological biogcnic amines.
The ef fec t of pH on the ac t iv i ty of monoamine
oxidase f rom rat brain with 4-hydroxy-3-
methoxy-benxylamine as substrate
The effect of pH on the activity of monoamine oxidasc
is shown in Figure 2. Activity was measured in the
normal way. The substrate concentration was 526 //mol/1.
The pH optimum with 4-hydroxy-3-methoxy-benzyl-
amine as substrate was found to be at about pH 9.0
(see Fig. 2).
The effect of some inhibitors of monoamine
oxidase
The production of vanillin in the assay appeared to
follow MICHAELIS-MENTEN kinetics with increasing
concentrations of the substrate 4-hydroxy-3-methoxy-
benzylamine. When monoamine oxidase-activity was
assayed in brain homogenate of rats which have been
injected intraperitoneally with irreversible monoamine
oxidase-inhibitors, such as iproniazid (5 mg/kg), par-
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Fig. 2
Effect of p H on the activity of monoamine oxidase from rat brain with
4-hydroxy-3-methoxy-benzylamine as substrate
The activities of monoamine oxidase were measured at 37°C. The sub-
strate concentrations used throughout were 526 //mol/1. The buffers
















1 1 1 1 1 1 1 1 1
0 2 4 6 8




Double reciprocal plots for 4-hydroxy-3-methoxy-benzyl-amlne oxid-
ation by monoamine oxidase from rat brain Ο— Ο reaction without
inhibitor; Ο Ο after pretreatment of rats with 0.2 mg/kg
tranylcypromine
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Fig. 4
Double reciprocal plots for 4-hydroxy-3-methoxy-benzyIamine oxid-
ation by monoamine oxidase from rat brain. Ο—Ο reaction without
inhibitor, χ—χ incubation in the presence of harmaline (100 //mol/1)
the inhibition observed appeared to be of non-com-
petitive and mixed-non-competitive type when the
data were analyzed according to LINEWEAVER and
BURK (see Fig. 3). When inhibitors such as harmaline
and amphetamine (10 mg/kg) were administered in vivo
no inhibition of monoamine oxidase could be found.
This finding can probably be explained by the fact that
the concentration of substrate in the incubation mix-
ture exceeds the concentration of inhibitor, e. g. the
concentration of amphetamine in the brain is about
100 μπιοΙ/1 (6) after application of 10 mg/kg.
When harmaline was present in the incubation mix-
ture (100 μ mol/1) it inhibited the reaction according to
a mixed-competitive type (see Fig. 4).
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Discussion
The attempts to elaborate a simple spectrophoto-
metric assay of monoamine oxidase activity resulted in
the introduction of different naturally not occurring
amines, e. g. benzylamine (7), ;#-iodo-benzylamine (8)
and jfr-dimethylamino-benzylamine (9). The application
of these benzylamines had at least one of the following
disadvantages:
1. When these benzylamine-derivatives are used as
substrates the absorption maxima of aldehydes pro-
duced by monoamine oxidase are below 280 nm. Thus,
absorbance due to unprecipitated protein or to sub-
stances present in the incubation mixture might interfere
with the absorbance of the aldehyde.
2. The turnover of the above mentioned benzylamines
is relatively low. Therefore, high substrate concen-
trations and long incubation times, respectively, must
be employed, or incubation must be performed under
pure oxygen (1).
3. The further metabolism of the aldehydes is not
fully elucidated. -The possibility cannot be excluded that
subsequent reaction products might interfere with the
measurement of aldehydes.
The 4-hydroxy-3-methoxy-benzylamine presented in
this paper as substrate for monoamine oxidase shows
not only a great structural similarity to the biogenic
phenylethylamines but is also an efficient substrate. The
Km-value is in the same order of magnitude as found
for biogenic amines. This substrate is oxidized by
monoamine oxidase under, air at a high rate, so that
low substrate concentrations and incubation times of
20—30 min are sufficient for the assay. The 4-hydroxy-
3-methoxy-benzaldehyde (vanillin) that is formed as the
primary oxidation product is not further metabolized
even in crude tissue homogenates. The measurement of
this product can be performed at 345 nm. Thus, there
are only few substances wich could interfere with the
absorbance due to vanillin.
The -optimum of non-purified monoamine oxidase
from rat brain towards 4-hydroxy-3-methoxy-benzyl-
amine as substrate was found to be at about pH 9.O. This
is not an extraordinary value for optimal pH conditions
of monoamine oxidase activity. In 1972, TIPTON reported
for monoamine oxidase preparations from rat liver a
pH optimum in the same order of magnitude with
benzylamine as substrate (10). MUSHAHWAR et al. also
found a pH optimum at pH 9.0 for a microsomal mono-
amine oxidase-preparation from bovine thyroid using
phenylethylamine as substrate (11).
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